Stephanie Watts - Publications

Biochemistry and Molecular Biology Michigan State University, East Lansing, MI 

127 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Gonzalez-Pons R, McRae K, Thompson JM, Watts SW. The 5-HT7 receptor restrains 5-HT-induced 5-HT2A mediated contraction in the isolated abdominal vena cava. Journal of Cardiovascular Pharmacology. PMID 34029269 DOI: 10.1097/FJC.0000000000001057  0.56
2021 Watts SW, Darios ES, Contreras GA, Garver H, Fink GD. Male and Female High Fat Fed Dahl SS rats are largely protected from vascular dysfunctions: PVAT contributions reveal sex differences. American Journal of Physiology. Heart and Circulatory Physiology. PMID 33929898 DOI: 10.1152/ajpheart.00131.2021  0.52
2021 Kumar RK, Yang Y, Contreras AG, Garver H, Bhattacharya S, Fink GD, Rockwell CE, Watts SW. Phenotypic Changes in T Cell and Macrophage Subtypes in Perivascular Adipose Tissues Precede High-Fat Diet-Induced Hypertension. Frontiers in Physiology. 12: 616055. PMID 33815135 DOI: 10.3389/fphys.2021.616055  0.52
2021 Orr AN, Thompson JM, Lyttle JM, Watts SW. Transglutaminases Are Active in Perivascular Adipose Tissue. International Journal of Molecular Sciences. 22. PMID 33808023 DOI: 10.3390/ijms22052649  0.56
2020 Restini CBA, Fink GD, Watts SW. Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved? Pharmacological Research. 105273. PMID 33197599 DOI: 10.1016/j.phrs.2020.105273  0.52
2020 Seitz BM, Fink GD, Watts SW. Activation of the 5-HT receptor but not nitric oxide synthase is necessary for chronic 5-hydroxytryptamine-induced hypotension. Experimental Physiology. PMID 33052620 DOI: 10.1113/EP088919  0.52
2020 Ferland DJ, Garver H, Contreras GA, Fink GD, Watts SW. Chemerin contributes to in vivo adipogenesis in a location-specific manner. Plos One. 15: e0229251. PMID 32092101 DOI: 10.1371/Journal.Pone.0229251  0.52
2020 Watts SW, Flood ED, Garver H, Fink GD, Roccabianca S. A New Function for Perivascular Adipose Tissue (PVAT): Assistance of Arterial Stress Relaxation. Scientific Reports. 10: 1807. PMID 32019956 DOI: 10.1038/S41598-020-58368-X  0.52
2019 Phan HTN, Jackson WF, Shaw V, Watts SW, Neubig RR. Loss-of-function mutations in human RGS2 differentially regulate pharmacological reactivity of resistance vasculature. Molecular Pharmacology. PMID 31645376 DOI: 10.1124/mol.119.116822  0.52
2019 Ferland DJ, Flood ED, Garver H, Yeh ST, Riney S, Mullick AE, Fink GD, Watts SW. Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high salt conditions. Physiological Genomics. PMID 31588871 DOI: 10.1152/Physiolgenomics.00050.2019  0.52
2019 Seitz BM, Demireva EY, Xie H, Fink GD, Krieger-Burke T, Burke WM, Watts SW. 5-HT does not lower blood pressure in the 5-HT knock-out rat. Physiological Genomics. PMID 31125292 DOI: 10.1152/Physiolgenomics.00031.2019  0.52
2019 Demireva EY, Xie H, Flood ED, Thompson JM, Seitz BM, Watts SW. Creation of the 5-hydroxytryptamine receptor 7 knockout (5-HTKO) Rat as a Tool for Cardiovascular Research. Physiological Genomics. PMID 31125290 DOI: 10.1152/physiolgenomics.00030.2019  0.56
2018 Ahmad MF, Ferland D, Ayala-Lopez N, Contreras GA, Darios E, Thompson J, Ismail A, Thelen K, Moeser AJ, Burnett R, Anantharam A, Watts SW. Perivascular Adipocytes Store Norepinephrine by Vesicular Transport. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA118311720. PMID 30567483 DOI: 10.1161/ATVBAHA.118.311720  0.32
2018 Kumar RK, Darios ES, Burnett R, Thompson JM, Watts SW. Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin. Pharmacological Research. PMID 30189295 DOI: 10.1016/j.phrs.2018.08.024  0.56
2018 Watts SW, Darios ES, Mullick AE, Garver H, Saunders TL, Hughes ED, Filipiak WE, Zeidler MG, McMullen N, Sinal CJ, Kumar RK, Ferland DJ, Fink GD. The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800479. PMID 29906243 DOI: 10.1096/Fj.201800479  0.52
2018 Ferland DJ, Seitz B, Darios ES, Thompson JM, Yeh ST, Mullick AE, Watts SW. Whole-body but not hepatic knockdown of chemerin by antisense oligonucleotide decreases blood pressure in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 29467310 DOI: 10.1124/jpet.117.245456  0.56
2018 Restini CBA, Ismail A, Kumar RK, Burnett R, Garver H, Fink GD, Watts SW. Renal perivascular adipose tissue: Form and function. Vascular Pharmacology. PMID 29454047 DOI: 10.1016/J.Vph.2018.02.004  0.52
2017 Seitz BM, Orer H, Krieger-Burke T, Darios ES, Thompson JM, Fink GD, Watts SW. 5-HT causes splanchnic venodilation. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00165.2017. PMID 28626072 DOI: 10.1152/Ajpheart.00165.2017  0.56
2017 Ayala-Lopez N, Thompson JM, Watts SW. Perivascular Adipose Tissue's Impact on Norepinephrine-Induced Contraction of Mesenteric Resistance Arteries. Frontiers in Physiology. 8: 37. PMID 28228728 DOI: 10.3389/fphys.2017.00037  0.56
2016 Ferland DJ, Darios ES, Neubig RR, Sjögren B, Truong N, Torres R, Dexheimer TS, Thompson JM, Watts SW. Chemerin-induced arterial contraction is Gi- and calcium-dependent. Vascular Pharmacology. PMID 27890480 DOI: 10.1016/j.vph.2016.11.009  0.56
2016 Seitz BM, Krieger-Burke T, Fink GD, Watts SW. Serial Measurements of Splanchnic Vein Diameters in Rats Using High-Frequency Ultrasound. Frontiers in Pharmacology. 7: 116. PMID 27199758 DOI: 10.3389/Fphar.2016.00116  0.52
2015 Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW. Organic Cation Transporter 3 Contributes to Norepinephrine Uptake into Perivascular Adipose Tissue. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00308.2015. PMID 26432838 DOI: 10.1152/ajpheart.00308.2015  1
2015 Young LW, Darios ES, Watts SW. An immunohistochemical analysis of SERT in the blood-brain barrier of the male rat brain. Histochemistry and Cell Biology. 144: 321-9. PMID 26223876 DOI: 10.1007/s00418-015-1343-1  1
2015 Darios ES, Barman SM, Orer HS, Morrison SF, Davis RP, Seitz BM, Burnett R, Watts SW. 5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation. European Journal of Pharmacology. 754: 140-7. PMID 25732865 DOI: 10.1016/j.ejphar.2015.02.032  1
2015 Watts SW, Darios ES, Seitz BM, Thompson JM. 5-HT is a potent relaxant in rat superior mesenteric veins. Pharmacology Research & Perspectives. 3: e00103. PMID 25692021 DOI: 10.1002/prp2.103  0.56
2015 Jespersen B, Tykocki NR, Watts SW, Cobbett PJ. Measurement of smooth muscle function in the isolated tissue bath-applications to pharmacology research. Journal of Visualized Experiments : Jove. 52324. PMID 25650585 DOI: 10.3791/52324  1
2015 Petersen-Jones HG, Johnson KB, Hitomi K, Tykocki NR, Thompson JM, Watts SW. Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls. American Journal of Physiology. Heart and Circulatory Physiology. 308: H592-602. PMID 25599570 DOI: 10.1152/Ajpheart.00402.2014  1
2014 Penumatsa K, Abualkhair S, Wei L, Warburton R, Preston I, Hill NS, Watts SW, Fanburg BL, Toksoz D. Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells. Cellular Signalling. 26: 2818-25. PMID 25218191 DOI: 10.1016/j.cellsig.2014.09.002  1
2014 Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 64: 1290-8. PMID 25201890 DOI: 10.1161/Hypertensionaha.114.03971  1
2014 Ayala-Lopez N, Martini M, Jackson WF, Darios E, Burnett R, Seitz B, Fink GD, Watts SW. Perivascular adipose tissue contains functional catecholamines. Pharmacology Research & Perspectives. 2: e00041. PMID 24904751 DOI: 10.1002/Prp2.41  0.52
2014 Tykocki NR, Wu B, Jackson WF, Watts SW. Divergent signaling mechanisms for venous versus arterial contraction as revealed by endothelin-1. Journal of Vascular Surgery. PMID 24726828 DOI: 10.1016/J.Jvs.2014.03.010  1
2013 Watts SW, Dorrance AM, Penfold ME, Rourke JL, Sinal CJ, Seitz B, Sullivan TJ, Charvat TT, Thompson JM, Burnett R, Fink GD. Chemerin connects fat to arterial contraction. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 1320-8. PMID 23559624 DOI: 10.1161/Atvbaha.113.301476  1
2013 Szasz T, Davis RP, Garver HS, Burnett RJ, Fink GD, Watts SW. Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Plos One. 8: e56046. PMID 23393607 DOI: 10.1371/Journal.Pone.0056046  1
2013 Davis RP, Szasz T, Garver H, Burnett R, Tykocki NR, Watts SW. One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat. Acs Chemical Neuroscience. 4: 141-8. PMID 23336053 DOI: 10.1021/Cn300114A  1
2013 Tykocki NR, Thompson JM, Jackson WF, Watts SW. Ryanodine receptors are uncoupled from contraction in rat vena cava. Cell Calcium. 53: 112-9. PMID 23177664 DOI: 10.1016/J.Ceca.2012.10.006  1
2012 Tykocki NR, Jackson WF, Watts SW. Reverse-mode Na+/Ca2+ exchange is an important mediator of venous contraction. Pharmacological Research. 66: 544-54. PMID 22974823 DOI: 10.1016/J.Phrs.2012.08.004  1
2012 Davis RP, Pattison J, Thompson JM, Tiniakov R, Scrogin KE, Watts SW. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved. Bmc Pharmacology. 12: 4. PMID 22559843 DOI: 10.1186/1471-2210-12-4  1
2012 Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacological Reviews. 64: 359-88. PMID 22407614 DOI: 10.1124/pr.111.004697  1
2012 Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker EN, Johnson GV, Colak G, Watts SW. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1355-66. PMID 22307675 DOI: 10.1152/Ajpheart.00918.2011  1
2011 Tan T, Watts SW, Davis RP. Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO Micro Infusion Pump: Programmable, Refillable, and Implantable. Frontiers in Pharmacology. 2: 44. PMID 21863140 DOI: 10.3389/fphar.2011.00044  1
2011 Watts SW, Shaw S, Burnett R, Dorrance AM. Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction. American Journal of Physiology. Heart and Circulatory Physiology. 301: H1236-47. PMID 21841011 DOI: 10.1152/Ajpheart.00384.2011  0.32
2011 Patrick Davis R, Linder AE, Watts SW. Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure. Naunyn-Schmiedeberg's Archives of Pharmacology. 383: 543-6. PMID 21448568 DOI: 10.1007/s00210-011-0622-1  1
2011 Dunlop J, Watts SW, Barrett JE, Coupet J, Harrison B, Mazandarani H, Nawoschik S, Pangalos MN, Ramamoorthy S, Schechter L, Smith D, Stack G, Zhang J, Zhang G, Rosenzweig-Lipson S. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 337: 673-80. PMID 21402690 DOI: 10.1124/jpet.111.179572  1
2011 Linder AE, Davis RP, Burnett R, Watts SW. Comparison of the function of the serotonin transporter in the vasculature of male and female rats. Clinical and Experimental Pharmacology & Physiology. 38: 314-22. PMID 21371073 DOI: 10.1111/j.1440-1681.2011.05504.x  1
2011 Watts SW, Davis RP. 5-hydroxtryptamine receptors in systemic hypertension: an arterial focus. Cardiovascular Therapeutics. 29: 54-67. PMID 20433685 DOI: 10.1111/j.1755-5922.2010.00173.x  1
2011 Watts SW. Extrinsic regulation of the vasculature Xpharm: the Comprehensive Pharmacology Reference. 1-5. DOI: 10.1016/B978-008055232-3.60333-2  1
2011 Watts SW. Regulation of the vasculature Xpharm: the Comprehensive Pharmacology Reference. 1-1. DOI: 10.1016/B978-008055232-3.60332-0  1
2011 Kanagy NL, Watts SW. Vascular smooth muscle contraction Xpharm: the Comprehensive Pharmacology Reference. 1-5. DOI: 10.1016/B978-008055232-3.60331-9  1
2011 Kanagy NL, Watts SW. Components of the vascular system Xpharm: the Comprehensive Pharmacology Reference. 1-3. DOI: 10.1016/B978-008055232-3.60330-7  1
2010 Johnson KB, Thompson JM, Watts SW. Modification of proteins by norepinephrine is important for vascular contraction. Frontiers in Physiology. 1: 131. PMID 21423373 DOI: 10.3389/fphys.2010.00131  1
2010 Szasz T, Linder AE, Davis RP, Burnett R, Fink GD, Watts SW. Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model. Journal of Cardiovascular Pharmacology. 56: 627-34. PMID 20881613 DOI: 10.1097/Fjc.0B013E3181F80194  1
2010 Northcott CA, Watts S, Chen Y, Morris M, Chen A, Haywood JR. Adenoviral inhibition of AT1a receptors in the paraventricular nucleus inhibits acute increases in mean arterial blood pressure in the rat. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 299: R1202-11. PMID 20702798 DOI: 10.1152/Ajpregu.00764.2009  1
2010 Tykocki NR, Watts SW. The interdependence of endothelin-1 and calcium: a review. Clinical Science (London, England : 1979). 119: 361-72. PMID 20662769 DOI: 10.1042/Cs20100145  1
2010 Linder AE, Gaskell GL, Szasz T, Thompson JM, Watts SW. Serotonin receptors in rat jugular vein: presence and involvement in the contraction. The Journal of Pharmacology and Experimental Therapeutics. 334: 116-23. PMID 20378714 DOI: 10.1124/jpet.109.163014  1
2010 Seymour EM, Bennink MR, Watts SW, Bolling SF. Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction. Hypertension. 55: 1179-85. PMID 20231522 DOI: 10.1161/Hypertensionaha.109.149393  1
2010 Szasz T, Watts SW. Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics. 333: 758-63. PMID 20215410 DOI: 10.1124/jpet.109.160184  0.44
2009 Szasz T, Eddy S, Paulauskis J, Burnett R, Ellekilde M, Iovanna JL, Watts SW. Differential expression of pancreatitis-associated protein and thrombospondins in arterial versus venous tissues. Journal of Vascular Research. 46: 551-60. PMID 19571575 DOI: 10.1159/000226223  1
2009 Watts SW, Priestley JR, Thompson JM. Serotonylation of vascular proteins important to contraction. Plos One. 4: e5682. PMID 19479059 DOI: 10.1371/journal.pone.0005682  0.8
2009 Tykocki NR, Gariepy CE, Watts SW. Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein. The Journal of Pharmacology and Experimental Therapeutics. 329: 875-81. PMID 19297422 DOI: 10.1124/Jpet.108.145953  1
2009 Linder AE, Beggs KM, Burnett RJ, Watts SW. Body distribution of infused serotonin in rats. Clinical and Experimental Pharmacology & Physiology. 36: 599-601. PMID 19207716 DOI: 10.1111/j.1440-1681.2009.05147.x  1
2008 Szasz T, Thompson JM, Watts SW. A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase. American Journal of Physiology. Heart and Circulatory Physiology. 295: H1341-H1350. PMID 18660442 DOI: 10.1152/ajpheart.00569.2008  0.56
2008 Ni W, Zhou H, Diaz J, Murphy DL, Haywood JR, Watts SW. Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse. European Journal of Pharmacology. 589: 225-7. PMID 18573249 DOI: 10.1016/J.Ejphar.2008.06.012  1
2008 Thakali K, Galligan JJ, Fink GD, Gariepy CE, Watts SW. Pharmacological endothelin receptor interaction does not occur in veins from ET(B) receptor deficient rats. Vascular Pharmacology. 49: 6-13. PMID 18485831 DOI: 10.1016/J.Vph.2008.03.005  1
2008 Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, Watts SW. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. British Journal of Pharmacology. 154: 663-74. PMID 18414394 DOI: 10.1038/Bjp.2008.111  1
2008 Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, Watts SW. A serotonergic system in veins: serotonin transporter-independent uptake. The Journal of Pharmacology and Experimental Therapeutics. 325: 714-22. PMID 18322152 DOI: 10.1124/Jpet.107.135699  1
2008 Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics. 325: 1031-8. PMID 18305011 DOI: 10.1124/Jpet.108.136226  1
2008 Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. American Journal of Physiology. Heart and Circulatory Physiology. 294: H1745-52. PMID 18263707 DOI: 10.1152/Ajpheart.91415.2007  1
2008 Watts SW, Kanagy NL, Lombard JH. Receptor-Mediated Events in the Microcirculation Microcirculation. 285-348. DOI: 10.1016/B978-0-12-374530-9.00007-3  1
2007 Watts SW, Thakali K, Smark C, Rondelli C, Fink GD. Big ET-1 processing into vasoactive peptides in arteries and veins. Vascular Pharmacology. 47: 302-12. PMID 17904426 DOI: 10.1016/J.Vph.2007.08.006  0.52
2007 Ogden KK, Falck JR, Watts SW. The cytochrome p450 inhibitor ketoconazole potentiates 5-hydroxytryptamine-induced contraction in rat aorta. The Journal of Pharmacology and Experimental Therapeutics. 323: 606-13. PMID 17687070 DOI: 10.1124/Jpet.107.128454  1
2007 Linder AE, Ni W, Diaz JL, Szasz T, Burnett R, Watts SW. Serotonin (5-HT) in veins: not all in vain. The Journal of Pharmacology and Experimental Therapeutics. 323: 415-21. PMID 17671100 DOI: 10.1124/Jpet.107.122630  1
2007 Linder AE, Thakali KM, Thompson JM, Watts SW, Webb RC, Leite R. Methyl-beta-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta. The Journal of Pharmacology and Experimental Therapeutics. 323: 78-84. PMID 17636007 DOI: 10.1124/Jpet.107.123463  1
2007 Rondelli CM, Szasz IT, Kayal A, Thakali K, Watson RE, Rovner AS, Eddinger TJ, Fink GD, Watts SW. Preferential myosin heavy chain isoform B Expression may contribute to the faster velocity of contraction in veins versus arteries. Journal of Vascular Research. 44: 264-72. PMID 17377397 DOI: 10.1159/000100991  1
2007 Ni W, Fink GD, Watts SW. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension. The Journal of Pharmacology and Experimental Therapeutics. 321: 485-91. PMID 17289838 DOI: 10.1124/Jpet.106.114017  1
2007 Watts SW, Rondelli C, Thakali K, Li X, Uhal B, Pervaiz MH, Watson RE, Fink GD. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 292: H2438-48. PMID 17237246 DOI: 10.1152/Ajpheart.00900.2006  1
2007 Szasz T, Thakali K, Fink GD, Watts SW. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Experimental Biology and Medicine (Maywood, N.J.). 232: 27-37. PMID 17202583 DOI: 10.3181/00379727-207-2320027  0.52
2007 Thakali K, Davenport L, Fink GD, Watts SW. Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. The Journal of Pharmacology and Experimental Therapeutics. 320: 236-43. PMID 17003231 DOI: 10.1124/Jpet.106.110650  1
2007 Priestley JR, Ni W, Watts S. Endogenous serotonin potentiates norepinephrine‐induced contraction of the superior mesenteric artery The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A517-B  1
2007 Thakali KM, Galligan JJ, Fink GD, Watts SW. Arterial and Venous Function in Hypertension Comprehensive Hypertension. 205-212. DOI: 10.1016/B978-0-323-03961-1.50022-2  1
2006 Ogden K, Thompson JM, Hickner Z, Huang T, Tang DD, Watts SW. A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2857-63. PMID 16861698 DOI: 10.1152/Ajpheart.00229.2006  1
2006 Thakali KM, Lau Y, Fink GD, Galligan JJ, Chen AF, Watts SW. Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function. Journal of Cardiovascular Pharmacology. 47: 742-50. PMID 16810074 DOI: 10.1097/01.Fjc.0000211789.37658.E4  1
2006 Ni W, Watts SW. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clinical and Experimental Pharmacology & Physiology. 33: 575-83. PMID 16789923 DOI: 10.1111/J.1440-1681.2006.04410.X  1
2006 Ni W, Lookingland K, Watts SW. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats. Hypertension. 48: 134-40. PMID 16754787 DOI: 10.1161/01.Hyp.0000225754.15146.Dd  1
2006 Thakali K, Davenport L, Fink GD, Watts SW. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension. 47: 482-7. PMID 16432037 DOI: 10.1161/01.Hyp.0000201540.91234.8F  1
2006 Ni W, Lookingland K, Watts SW. Response to blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter [8] Hypertension. 48: e117. DOI: 10.1161/01.Hyp.0000246309.64175.69  1
2005 Xu H, Bian X, Watts SW, Hlavacova A. Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats. Hypertension. 46: 1154-62. PMID 16216988 DOI: 10.1161/01.Hyp.0000186278.50275.Fa  1
2005 Northcott CA, Hayflick J, Watts SW. Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility. Clinical and Experimental Pharmacology & Physiology. 32: 851-8. PMID 16173947 DOI: 10.1111/J.1440-1681.2010.04276.X  1
2005 Thakali K, Demel SL, Fink GD, Watts SW. Endothelin-1-induced contraction in veins is independent of hydrogen peroxide. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1115-22. PMID 15908460 DOI: 10.1152/Ajpheart.00086.2005  1
2005 Ni W, Wilhelm CS, Bader M, Murphy DL, Lookingland K, Watts SW. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 314: 953-60. PMID 15901794 DOI: 10.1124/Jpet.105.087080  1
2005 Toews ML, Watts SW, Beckman BS. Preserving and promoting our discipline: pharmacology students speak out. Molecular Interventions. 5: 4-7. PMID 15731498 DOI: 10.1124/Mi.5.1.1  1
2005 Wang H, Chen AF, Watts SW, Galligan JJ, Fink GD. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 288: H729-36. PMID 15471983 DOI: 10.1152/Ajpheart.00388.2004  1
2005 Atkins KB, Northcott CA, Watts SW, Brosius FC. Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. American Journal of Physiology. Heart and Circulatory Physiology. 288: H235-43. PMID 15345487 DOI: 10.1152/Ajpheart.00643.2004  1
2004 Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW. The serotonin transporter is present and functional in peripheral arterial smooth muscle. Journal of Cardiovascular Pharmacology. 43: 770-81. PMID 15167270 DOI: 10.1097/00005344-200406000-00006  1
2004 Slovut DP, Mehta SH, Dorrance AM, Brosius FC, Watts SW, Webb RC. Increased vascular sensitivity and connexin43 expression after sympathetic denervation. Cardiovascular Research. 62: 388-96. PMID 15094358 DOI: 10.1016/J.Cardiores.2003.12.024  0.44
2004 Thakali K, Fink GD, Watts SW. Arteries and veins desensitize differently to endothelin. Journal of Cardiovascular Pharmacology. 43: 387-93. PMID 15076222 DOI: 10.1097/00005344-200403000-00009  0.52
2004 Dai X, Galligan JJ, Watts SW, Fink GD, Kreulen DL. Increased O2*- production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension. 43: 1048-54. PMID 15051669 DOI: 10.1161/01.Hyp.0000126068.27125.42  1
2004 Northcott CA, Hayflick JS, Watts SW. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit? Hypertension. 43: 885-90. PMID 14993194 DOI: 10.1161/01.Hyp.0000118518.20331.E8  1
2004 Wehrwein EA, Northcott CA, Loberg RD, Watts SW. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. The Journal of Pharmacology and Experimental Therapeutics. 309: 1011-9. PMID 14982964 DOI: 10.1124/Jpet.103.062265  1
2004 Ni W, Li MW, Thakali K, Fink GD, Watts SW. The fenfluramine metabolite (+)-norfenfluramine is vasoactive. The Journal of Pharmacology and Experimental Therapeutics. 309: 845-52. PMID 14752059 DOI: 10.1124/Jpet.103.060806  1
2004 Watts SW, Thompson JM. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. The Journal of Pharmacology and Experimental Therapeutics. 309: 165-72. PMID 14724222 DOI: 10.1124/jpet.103.062562  0.56
2004 Northcott CA, Watts SW. Low [Mg2+]e enhances arterial spontaneous tone via phosphatidylinositol 3-kinase in DOCA-salt hypertension. Hypertension. 43: 125-9. PMID 14638620 DOI: 10.1161/01.Hyp.0000103631.68328.03  1
2003 Banes AK, Watts SW. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. Bmc Pharmacology. 3: 12. PMID 12974983 DOI: 10.1186/1471-2210-3-12  1
2003 Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension. 42: 316-21. PMID 12885792 DOI: 10.1161/01.Hyp.0000084853.47326.F2  1
2003 Loberg RD, Northcott CA, Watts SW, Brosius FC. PI3-kinase-induced hyperreactivity in DOCA-salt hypertension is independent of GSK-3 activity. Hypertension. 41: 898-902. PMID 12629035 DOI: 10.1161/01.Hyp.0000061762.58873.2F  1
2003 Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation. 107: 1053-8. PMID 12600921 DOI: 10.1161/01.Cir.0000051459.74466.46  1
2002 Russell A, Banes A, Berlin H, Fink GD, Watts SW. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat. The Journal of Pharmacology and Experimental Therapeutics. 303: 179-87. PMID 12235249 DOI: 10.1124/Jpet.102.037390  0.52
2002 Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circulation Research. 91: 360-9. PMID 12193470 DOI: 10.1161/01.Res.0000030861.13850.F1  1
2002 Watts SW, Fink GD, Northcott CA, Galligan JJ. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists. British Journal of Pharmacology. 137: 69-79. PMID 12183332 DOI: 10.1038/Sj.Bjp.0704831  1
2002 Johnson RJ, Fink GD, Watts SW, Galligan JJ. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats. Journal of Hypertension. 20: 665-76. PMID 11910302 DOI: 10.1097/00004872-200204000-00024  1
2002 Watts SW. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension. 39: 825-9. PMID 11897772 DOI: 10.1161/hy0302.104668  1
2002 Banes AK, Watts SW. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension. Hypertension. 39: 394-8. PMID 11882579  1
2001 Northcott C, Florian JA, Dorrance A, Watts SW. Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension Hypertension. 38: 1337-1341. PMID 11751714 DOI: 10.1161/Hy1201.096815  1
2001 Banes AK, Loberg RD, Brosius FC, Watts SW. Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells. Bmc Pharmacology. 1: 8. PMID 11667949 DOI: 10.1186/1471-2210-1-8  1
2001 Banes AK, Watts SW. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat. Hypertension. 38: 891-5. PMID 11641304  1
2001 Watts SW, Yang P, Banes AK, Baez M. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. Journal of Cardiovascular Pharmacology. 38: 539-51. PMID 11588524 DOI: 10.1097/00005344-200110000-00006  1
2001 Atkins KB, Johns D, Watts S, Webb RC, Brosius FC. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. Journal of Hypertension. 19: 1581-1587. PMID 11564977 DOI: 10.1097/00004872-200109000-00009  0.44
2001 Florian JA, Dorrance A, Webb RC, Watts SW. Mineralocorticoids upregulate arterial contraction to epidermal growth factor American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 281. PMID 11507004 DOI: 10.1152/Ajpregu.2001.281.3.R878  1
2000 Melis A, Watts SW, Florian J, Klarr S, Webb RC. Insulin-like growth factor inhibits vascular contraction to 5- hydroxytryptamine: Involvement of tyrosine phosphatase General Pharmacology. 34: 137-145. PMID 10974421 DOI: 10.1016/S0306-3623(00)00055-0  1
2000 Watts SW, Fink GD, Silver PJ, Cushing DJ. Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors. Journal of Cardiovascular Pharmacology. 35: 29-36. PMID 10630730 DOI: 10.1097/00005344-200001000-00004  0.52
1999 Florian JA, Watts SW. Epidermal growth factor: A potent vasoconstrictor in experimental hypertension American Journal of Physiology - Heart and Circulatory Physiology. 276. PMID 10070082 DOI: 10.1152/ajpheart.1999.276.3.H976  1
1999 Watts SW, Fink GD. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. The American Journal of Physiology. 276: H944-52. PMID 10070078 DOI: 10.1152/Ajpheart.1999.276.3.H944  0.52
1998 Monroe KK, Watts SW. The vascular reactivity of melatonin General Pharmacology. 30: 31-35. DOI: 10.1016/S0306-3623(97)00090-6  1
1997 Tithof PK, Watts S, Ganey PE. Protein tyrosine kinase involvement in the production of superoxide anion by neutrophils exposed to aroclor 1242, a mixture of polychlorinated biphenyls Biochemical Pharmacology. 53: 1833-1842. PMID 9256158 DOI: 10.1016/S0006-2952(97)82447-1  1
1997 Grekin RJ, Dumont CJ, Vollmer AP, Watts SW, Webb RC. Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 273. PMID 9249567  1
1995 Watts SW, Chai S, Clinton Webb R. Lead acetate-induced contraction in rabbit mesenteric artery: Interaction with calcium and protein kinase C Toxicology. 99: 55-65. PMID 7762002 DOI: 10.1016/0300-483X(94)03003-K  1
1994 Watts SW, Cohen ML, Mooney PQ, Johnson BG, Schoepp DD, Baez M. Disruption of potential alpha-helix in the G loop of the guinea pig 5-hydroxytryptamine2 receptor does not prevent receptor coupling to phosphoinositide hydrolysis. Journal of Neurochemistry. 62: 934-43. PMID 8113814 DOI: 10.1046/j.1471-4159.1994.62030934.x  1
1994 Watts SW, Finta KM, Lloyd MC, Storm DS, Webb RC. Enhanced vascular responsiveness to Bay K 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension. Blood Pressure. 3: 340-8. PMID 7532526 DOI: 10.3109/08037059409102284  1
Show low-probability matches.